AI Accelerates Early-Stage Drug Development for Major Pharmaceutical Companies
Trendline

AI Accelerates Early-Stage Drug Development for Major Pharmaceutical Companies

What's Happening? Artificial intelligence (AI) is significantly speeding up early-stage drug development for some of the world's largest pharmaceutical companies, including Bristol Myers Squibb, Novartis, Eli Lilly, Sanofi, Novo Nordisk, and AstraZeneca. According to Reuters, AI has cut the time req
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.